441 related articles for article (PubMed ID: 15318753)
1. [Medical treatment of unruptured ectopic pregnancy].
Rojas Mora E; Hernández Vivar LE; Sánchez Contreras J; Risco Cortés RJ; Pulido Olivares VH
Ginecol Obstet Mex; 2004 Apr; 72():135-41. PubMed ID: 15318753
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of expectant management versus methotrexate in tubal ectopic pregnancy: a double-blind randomized trial.
Silva PM; Araujo Júnior E; Cecchino GN; Elito Júnior J; Camano L
Arch Gynecol Obstet; 2015 Apr; 291(4):939-43. PubMed ID: 25315383
[TBL] [Abstract][Full Text] [Related]
3. Fertility outcome following combined methotrexate treatment of unruptured extrauterine pregnancy.
Debby A; Golan A; Sadan O; Zakut H; Glezerman M
BJOG; 2000 May; 107(5):626-30. PubMed ID: 10826577
[TBL] [Abstract][Full Text] [Related]
4. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
[TBL] [Abstract][Full Text] [Related]
5. Comparison of single and multiple dose methotrexate therapy for unruptured tubal ectopic pregnancy: a prospective randomized study.
Guvendag Guven ES; Dilbaz S; Dilbaz B; Aykan Yildirim B; Akdag D; Haberal A
Acta Obstet Gynecol Scand; 2010 Jul; 89(7):889-95. PubMed ID: 20583934
[TBL] [Abstract][Full Text] [Related]
6. A randomised trial comparing single dose systemic methotrexate and laparoscopic surgery for the treatment of unruptured tubal pregnancy.
Sowter MC; Farquhar CM; Petrie KJ; Gudex G
BJOG; 2001 Feb; 108(2):192-203. PubMed ID: 11236120
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of systemic methotrexate in the treatment of unruptured tubal pregnancy.
Soliman KB; Saleh NM; Omran AA
Saudi Med J; 2006 Jul; 27(7):1005-10. PubMed ID: 16830020
[TBL] [Abstract][Full Text] [Related]
8. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
[TBL] [Abstract][Full Text] [Related]
9. Predictors of methotrexate treatment failure in ectopic pregnancy.
Dilbaz S; Caliskan E; Dilbaz B; Degirmenci O; Haberal A
J Reprod Med; 2006 Feb; 51(2):87-93. PubMed ID: 16572908
[TBL] [Abstract][Full Text] [Related]
10. Outcome, complications and future fertility in women treated with uterine artery embolization and methotrexate for non-tubal ectopic pregnancy.
Krissi H; Hiersch L; Stolovitch N; Nitke S; Wiznitzer A; Peled Y
Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():172-6. PubMed ID: 25300059
[TBL] [Abstract][Full Text] [Related]
11. Serum β-hCG levels post-treatment of ectopic pregnancy with a single dose of intramuscular methotrexate.
Hadinata IE; Doyle LW; Thompson D; Reti L
Aust N Z J Obstet Gynaecol; 2015 Apr; 55(2):181-4. PubMed ID: 25898911
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of ruptured with hemodynamically stable and unruptured ectopic pregnancy patients.
Kumtepe Y; Kadanali S
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):221-5. PubMed ID: 15358469
[TBL] [Abstract][Full Text] [Related]
13. The predictors of successful methotrexate treatment of tubal ectopic pregnancy.
Abdelfattah-Arafa E; Abdussalam HF; Omar Saad M; El Ansari W
J Obstet Gynaecol; 2024 Dec; 44(1):2361456. PubMed ID: 38864434
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ectopic pregnancy with a single intramuscular dose of methotrexate.
Alshimmiri MM; Al-Saleh EA; Al-Harmi JA; AlSalili MB; Adwani AA; Ibrahim ME
Arch Gynecol Obstet; 2003 Aug; 268(3):181-3. PubMed ID: 12942247
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for the methotrexate treatment outcome in ectopic pregnancy: A comparative study of 400 cases.
Bonin L; Pedreiro C; Moret S; Chene G; Gaucherand P; Lamblin G
Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():23-30. PubMed ID: 27888702
[TBL] [Abstract][Full Text] [Related]
16. Multidose Methotrexate Treatment of Ectopic Pregnancies with High initial β-Human Chorionic Gonadotropin: Can Success Be Predicted?
Tug N; Sargin MA; Yassa M
Gynecol Obstet Invest; 2019; 84(1):56-63. PubMed ID: 30099453
[TBL] [Abstract][Full Text] [Related]
17. The optimal cutoff serum level of human chorionic gonadotropin for efficacy of methotrexate treatment in women with extrauterine pregnancy.
Sagiv R; Debby A; Feit H; Cohen-Sacher B; Keidar R; Golan A
Int J Gynaecol Obstet; 2012 Feb; 116(2):101-4. PubMed ID: 22093497
[TBL] [Abstract][Full Text] [Related]
18. Assessment of β-human chorionic gonadotropin level as a reliable predictor of tubal patency confirmed with transvaginal ultrasound-guided selective salpingography (TVSSG) following conservative treatment of tubal pregnancy.
Al Sayed I
Arch Gynecol Obstet; 2012 Apr; 285(4):1043-8. PubMed ID: 22002409
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of medical treatment with methotrexate for interstitial pregnancy.
Hiersch L; Krissi H; Ashwal E; From A; Wiznitzer A; Peled Y
Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):576-80. PubMed ID: 25338827
[TBL] [Abstract][Full Text] [Related]
20. Medical management of ectopic pregnancy with extremely high beta-HCG levels: a case report.
Yüce MA; Gücer F; Balkanli-Kaplan P; Sayin NC
Clin Exp Obstet Gynecol; 2004; 31(3):242-3. PubMed ID: 15491075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
